CXCL12 and neoplasm: This study aims to explore the application of self‐assembled M2pep‐Cs NPs/Plerixafor NPs in targeting the CXCL12–CXCR4 pathway and reprogramming TAMs to enhance immune‐mediated tumor elimination in GC.